Risky Business Of FDA Mobile Medical Apps

Law360, New York (October 31, 2013, 5:45 PM EDT) -- The U.S. Food and Drug Administration has issued final guidance[1] on mobile medical applications, which are mobile apps that meet the definition of a device[2] and are intended to be used as an accessory to a regulated medical device or to transform a mobile platform into a regulated medical device. Mobile apps are software applications that are run through mobile platforms (e.g., smartphones, tablet computers and other handheld computing platforms) or certain web-based software applications.

The final guidance states that the FDA will apply its regulatory authority...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.